Subscribe to Drug Discovery & Development News

The Lead

Electronic Micropump Could Deliver Treatment to Specific Brain Region

April 17, 2015 | by Stephanie Guzowski, Editor | Comments

There is an exactness that must be taken into account when treating neurological disorders. In treating epilepsy, for example, a condition in which nerve cell activity in the brain is disturbed, causing seizures, a drug needs to be delivered directly to a specific brain region—but without negatively affecting healthy brain regions. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Perrigo Launches Generic Nasal Spray

April 17, 2015 4:18 pm | Comments

Perrigo Company plc announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun Pharma's Kenalog nasal spray. Read more...


Brain Tumors May be New Victims of Ebola-like Virus

April 17, 2015 3:53 pm | by Yale University | Comments

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers — portions of a deadly virus similar to Ebola. Read more...

Greater Function after Stroke When Blood Clots Removed from Brain

April 17, 2015 3:48 pm | by UPMC | Comments

A technique that removes blood clots from large brain blood vessels reduced disability after stroke in a trial conducted in Catalonia, Spain, and co-led by an expert from the University of Pittsburgh School of Medicine. Read more...


Genetic Mutation Could Be Start of Malaria Drug Resistance in Africa

April 17, 2015 3:38 pm | by London School of Hygiene & Tropical Medicine | Comments

Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy. Read more...


Glaxo Recalls Flu Vaccine Due to Potency Problem

April 17, 2015 3:25 pm | by Matthew Perrone, AP Business Writer | Comments

GlaxoSmithKline is recalling a popular four-in-one flu vaccine because its effectiveness can decline over time. Read more...


Rare, Deadly Lymphoma Demystified

April 17, 2015 10:46 am | by Columbia University | Comments

The first-ever systematic study of the genomes of patients with ALK-negative anaplastic large cell lymphoma (ALCL), a particularly aggressive form of non-Hodgkin’s lymphoma (NHL), shows that many cases of the disease are driven by alterations in the JAK/STAT3 cell signaling pathway. Read more...


The Placebome?

April 17, 2015 10:29 am | by Harvard Medical School | Comments

How genomics might influence the role of the placebo in patient care and clinical research...


Synthetic Drugs: Evidence That They Can Cause Cancer

April 17, 2015 8:19 am | by Medical University of Vienna | Comments

Synthetic cannabinoids are difficult to identify chemically and the possible unwanted toxic effects that can occur following their consumption have so far barely been investigated. Read more...


Gene Variant Linked to Cancer

April 17, 2015 8:11 am | by Washington University in St. Louis | Comments

Smokers with a specific genetic variation are more likely to keep smoking longer than those who don’t have the gene variant. Read more...


Scientists Discover Protein That Boosts Immunity to Viruses and Cancer

April 17, 2015 8:10 am | by Imperial College London | Comments

Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies. Read more...


Evidence Grows that Melanoma Drugs Benefit Some Lung Cancer Patients

April 17, 2015 8:09 am | by European Society for Medical Oncology | Comments

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma. Read more...


Pfizer Breast Cancer Drug Shows Promising Results

April 16, 2015 2:19 pm | by Stephanie Guzowski, Editor | Comments

Pfizer said on Wednesday a late-stage trial of its treatment for advanced breast cancer, Ibrance, was stopped early after it met its primary goal of delaying disease progression. Read more...


Identifying Molecular Mechanism That Makes Malaria Parasites Drug-Resistant

April 16, 2015 12:57 pm | by University of Notre Dame | Comments

University of Notre Dame researchers led an international team to identify a molecular mechanism responsible for making malaria parasites resistant to artemisinins, the leading class of antimalarial drugs. Read more...


Abbot Receives FDA Clearance for New Blood Glucose Meter

April 16, 2015 10:38 am | Comments

The cost of insurance premiums and employee medical claims continues to rise in the United States, which is especially challenging for people living with chronic conditions such as diabetes. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.